Continue to slide 2 »

#21. Edwards Lifesciences Corp (EW) — 27% UPSIDE

Company Name:  Edwards Lifesciences Corp
Sector:  Medical Instruments & Supplies

Edwards Lifesciences is engaged in patient-focused medical for structural heart disease, as well as critical care and surgical monitoring. Co. is a manufacturer of heart valve systems and repair products used to replace or repair a patient's diseased or defective heart valve. Co. is also engaged in hemodynamic and noninvasive brain and tissue oxygenation monitoring systems used to measure a patient's cardiovascular function in the hospital setting. Co.'s products and technologies are categorized into four main areas: Transcatheter Aortic Valve Replacement, Transcatheter Mitral and Tricuspid Therapies, Surgical Structural Heart, and Critical Care. The median 12 month forward target price among analysts covering EW is $85.0/share.

Continue to slide 2 »
Quotes delayed 20 minutes
Get Free SEC filing alerts for EW:
EW SEC Filing Email Alerts ServiceExternal link
 

21 Growth Stocks For 2021 - Page 1 | www.RediNews.com | Copyright © 2013 - 2020, All Rights Reserved

Nothing in RediNews.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and market videos powered by Market News Video.